Showing 2531-2540 of 3045 results for "".
- Record Growth Noted for PCA SKINhttps://practicaldermatology.com/news/record-growth-noted-for-pca-skin/2458076/PCA SKIN® ranked as the #2 fastest growing professional skincare brand in 2017, according to the global market research and management consulting firm, Kline. Kline Company lists PCA SKIN as hav
- Protea Expands Clinical Study for New Melanoma Testhttps://practicaldermatology.com/news/protea-expands-clinical-study-for-new-melanoma-test/2458083/Protea Biosciences Group, Inc. is expanding its clinical research study for their new molecular imaging test for the differential diagnosis of malignant melanoma. The study has now surpassed 250 patient samples, the company reports. The propr
- Power Couple: Stroll Health Teams Up With First Dermhttps://practicaldermatology.com/news/power-couple-stoll-health-teams-up-with-first-derm/2458085/Stroll Health and First Derm are partnering to make dermatology care more accessible and available at a fair price. Stroll's health care 
- Isdin Launches Nutraseb™ for Facial Seborrheic Dermatitishttps://practicaldermatology.com/news/isdin-launches-nutraseb-for-facial-seborrheic-dermatitis/2458089/Isdin is rolling out Nutraseb™ Facial Cream, a new steroid-free topical Rx for the multi-symptom management of facial seborrhea and seborrheic dermatitis (SD). Nutraseb™ is a fragranc
- Revision Skincare Launches Nectifirm Advancedhttps://practicaldermatology.com/news/revision-skincare-launches-nectifirm-advanced/2458090/Revision Skincare® is expanding the Nectifirm® collection with Nectifirm® ADVANCED. Nectifirm® ADVANCED harnesses the power of the Microbiome for maintaining skin
- Researchers Close in on Cause of Inflammation in Rosaceahttps://practicaldermatology.com/news/researchers-close-in-on-cause-of-inflammation-in-rosacea/2458091/Once developed, therapies that block TRPV4 may help treat or prevent inflammation in patients with rosacea, according to new research funded by the National Rosacea Society (NRS). In earlier research, the team l
- New Criteria Aims to Help Doctors Spot Amelanotic Melanoma Earlierhttps://practicaldermatology.com/news/new-criteria-aims-to-help-doctors-spot-amelanotic-melanoma-earlier/2458092/New research outlines key features linked to amelanotic melanoma. The findings, which appear in JAMA Dermatology, may help improve detection of this type of melanoma, which is more likely to be diagnosed at advanced stages because it falls outside of the “ABCDE” guide
- Boehringer Ingelheim Begins Interchangeability Study Between Adalimumab Biosim and Humirahttps://practicaldermatology.com/news/boehringer-ingelheim-begins-interchangeability-study-between-adalimumab-biosim-and-humira/2458106/The first patient has been enrolled into the VOLTAIRE-X interchangeability study, which seeks to demonstrate that BI 695501 is interchangeable with the U.S.-marketed formulation of Humira®* 40 mg/0.8 ml. This is the first study in the U.S. to investigate an interchange
- Study IDs Risk Factors for Melanoma in Kidney Transplant Recipientshttps://practicaldermatology.com/news/study-ids-risk-factors-for-melanoma-in-kidney-transplant-recipients/2458108/Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results demonstrated in other studies, according to a new article published by
- Innovation in Action: Meet the DNA Sunscreen that Gets Better the Longer You Wear Ithttps://practicaldermatology.com/news/innovation-in-action-meet-a-dna-sunscreen-that-gets-better-the-longer-you-wear-it/2458109/Researchers at Binghamton University, State University of New York have developed a coating made out of DNA that gets better at protecting skin from Ultraviolet light the more you expose it to the sun, and it also keeps your skin hydrated. “Ultraviolet (UV) light can actually damage